Trial Profile
The multifaceted investigation for the beneficial effect of improvement of postprandial hyperglycemia on development of frailty or sarcopenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2021
Price :
$35
*
At a glance
- Drugs Mitiglinide/voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 16 Jul 2021 Status changed from recruiting to completed.
- 20 Sep 2018 Status changed from not yet recruiting to recruiting.
- 02 Feb 2018 New trial record